TC Biopharm (Holdings) Plc (TCBP) Stock Price & Growth Analysis

New

Chrome Plugin Live! Redefine the way you read FinTwit 🚀 Install Now

You have successfully sign out

TC Biopharm (Holdings) Plc

TCBP

NASDAQ

Unprofitable

EPS improving

Unprofitable

EPS improving

256496

Biotechnology

0.50USD

0.00 ( 0.00%)

Market Closed (as of Mar 21, 20:00 EDT)

Relative Strenght

Volume Buzz

1461%

Earning Acce

Yes

Dist 52w H.

100%

Overview Chart

Quote Panel

Updated July 2, 2025

1W % 1M % 3M 63.27 % 1Y -99.66 %

Key Metrics

Market Cap
256496
Shares Outstanding
2565
Share in Float
2472
Dividende
0

Earning Date
No Data
Price Target
0.5
Average Volume
377721
Beta
0.012

Range
0.08-523.2
Industry
Biotechnology
Website
https://www.tcbiopharm.com
Sector
Healthcare

Fundamentals

N/A

P/E Ratio

0.00x

P/S Ratio

1.18x

P/B Ratio

0.8

Debt/Equity

0.0%

Net Margin

$-4794.4

EPS

How TCBP compares to sector?

P/E Ratio

Fundamentals

Relative Strength

TCBP

Sector

Top 5 RS in Group

Symbol	Company	RS	5-Day Perf.

Relative Strength

TCBP

Sector

Top 5 RS in Group

Symbol	Company	RS	5-Day Perf.

Forecast

No Data Available

Analyst rating

Strong Sell

Sell

Buy

Neutral

Strong Buy

Buy

Price Target

NaN(-100.00%)

Number of analyst

Last analyst upgrade/downgrade

No Data Available

Earnings Growth

YoY

Current

Estimates

Q2.22

+114%

0.02
vs -0.16

Q3.22

N/A

-0.07
vs -0.85

Q4.22

N/A

-0.08
vs -0.67

Q1.23

N/A

-0.02
vs 0.03

Q2.23

-82%

0
vs 0.02

Q3.23

N/A

-0.02
vs -0.07

Q4.23

N/A

-0.02
vs -0.08

Q1.24

N/A

-2.80
vs -0.02

Q2.24

N/A

-0.00
vs 0

Q3.24

+5862%

1.18
vs -0.02

Sales Growth

YoY

Current

Estimates

Q1.22

494.7K vs 494.7K

Q2.22

494.7K vs 494.7K

Q3.22

+189%

1.4M vs 494.7K

Q4.22

+189%

1.4M vs 494.7K

Q1.23

-100%

NA vs 494.7K

Q2.23

-100%

NA vs 494.7K

Q3.23

-100%

NA vs 1.4M

Q4.23

-100%

NA vs 1.4M

Q1.24

NA vs NA

Q2.24

NA vs NA

Return on Equity

QoQ

Q3.22

-276%

-2.76
vs 0.25

Q4.22

-276%

-2.76
vs -2.76

Q1.23

-192%

-1.92
vs -2.76

Q2.23

+11%

0.11
vs -1.92

Q3.23

-117%

-1.17
vs 0.11

Q4.23

-117%

-1.17
vs -1.17

Q1.24

-307%

-3.07
vs -1.17

Q2.24

-99%

-0.99
vs -3.07

Institutionnal Ownership

QoQ

Q1.22

8
vs NA

Q2.22

5
vs 8

-37%

Q3.22

5
vs 5

Earnings Growth

Latest News

prnewswire.com

8 hours ago

TC BioPharm Announces Complete Response in Minimal Residual Disease (MRD) Patient

prnewswire.com

8 hours ago

TCBP Announces Outsourcing Initiatives, Reducing Burn Rate and Overhead

prnewswire.com

8 hours ago

TCBP Announces Non-Binding Letter of Intent to Acquire Commercial Stage Ophthalmic Pharmaceutical Company

prnewswire.com

8 hours ago

TCBP CEO Bryan Kobel to Participate on Cancer Progress Panel at 18th Annual European Life Sciences CEO Forum

prnewswire.com

8 hours ago

TCBP Announces Successful Completion of Cohort A in the ACHIEVE Clinical Trial

prnewswire.com

10 hours ago

TCBP Announces Transition from Nasdaq to OTC Markets